TO: RGS Fundopp Subscribers 02-392
Subject: Barth Syndrome Foundation
Information as of May 16, 2002
**********************************************************************
Note: If you are interested in applying to a foundation, please
contact Betty Leidal, Director of Foundation Relations, at 824-6248.
SCOPE: The Barth Syndrome Foundation is inviting grant applications
for research on this disease, a frequently fatal genetic disorder
affecting boys. Barth Syndrome is an X-linked recessive,
cardioskeletal myopathy associated with neutropenia, growth delay, and
diverse biochemical abnormalities, among which are defects in
mitochondrial metabolism and phospholipid biosynthesis.
DEADLINE: Letters of intent are due June 30.
FUNDS: Up to $100,000 will be available for multiple one- or two-year
seed funding grants ranging from $10,000 to $40,000.
ELIGIBILITY: Principal investigators affiliated with nonprofit
institutions.
AREAS: Because many clinical and biochemical abnormalities of Barth
Syndrome remain poorly understood, the Foundation is seeking proposals
for research that may shed light on any aspect of the syndrome. The
goal is to find treatments, and ultimately a cure, for this rare
disorder.
CONTACT: Kate McCurdy, Vice President, Science and Medicine, Barth
Syndrome Foundation, Inc., P.O. Box 618, Larchmont, NY 10538,
914-834-1771, email kmccurdy@barthsyndrome.org.
The announcement is available online at
http://www.barthsyndrome.org .
**********************************************************************
Custom funding searches are available by contacting Beth Riley,
824-3951, email briley@uci.edu. Grant proposal editing services are
available by contacting Randy Black, 824-7912, email rbblack@uci.edu.
RGS Fundopp is a service of the UCI Office of Research Development and
is intended for the sole use of UCI employees. To subscribe to RGS
Fundopp, visit the Zotmail homepage at
http://www.zotmail.uci.edu/ . Follow the instructions, and select RGS
Fundopp. For questions or comments, contact Beth Riley.
**********************************************************************
|